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Neuregulin-1 (NRG1) gene variants are associated
with increased genetic risk for schizophrenia. It is
unclear whether risk haplotypes cause elevated
or decreased expression of NRG1 in the brains of
schizophrenia patients, given that both findings
have been reported from autopsy studies. To study
NRG1 functions in vivo, we generated mouse mu-
tants with reduced and elevated NRG1 levels and
analyzed the impact on cortical functions. Loss of
NRG1 from cortical projection neurons resulted in
increased inhibitory neurotransmission, reduced
synaptic plasticity, and hypoactivity. Neuronal over-
expression of cysteine-rich domain (CRD)-NRG1,
the major brain isoform, caused unbalanced ex-
citatory-inhibitory neurotransmission, reduced syn-
aptic plasticity, abnormal spine growth, altered
steady-state levels of synaptic plasticity-related
proteins, and impaired sensorimotor gating. We
conclude that an ‘‘optimal’’ level of NRG1 signaling
balances excitatory and inhibitory neurotransmis-
sion in the cortex. Our data provide a potential path-
omechanism for impaired synaptic plasticity and
suggest that human NRG1 risk haplotypes exert a
gain-of-function effect.1130 Cell Reports 8, 1130–1145, August 21, 2014 ª2014 The AuthorINTRODUCTION
Neuregulin-1 (NRG1) is a pleiotropic growth and differentiation
factor, which signals to receptor tyrosine kinases of the ErbB
family (Falls, 2003). The human NRG1 gene is a major schizo-
phrenia susceptibility gene (Ayalew et al., 2012; Li et al., 2006),
but the underlying link to pathophysiology is not known. Virtually
all ‘‘at-risk’’ haplotypes map to noncoding regions of the human
NRG1 gene (Stefansson et al., 2002; Weickert et al., 2012), sug-
gesting that altered NRG1 expression increases disease sus-
ceptibility. Indeed, both reduced and increased expression of
distinct NRG1 variants have been observed in studies of post-
mortem brain tissue from schizophrenia patients (Bertram
et al., 2007; Law et al., 2006). This includes elevated expression
of membrane-bound ‘‘cysteine-rich domain’’ (CRD)-NRG1
(Weickert et al., 2012), the predominant NRG1 isoform in the hu-
man brain (Liu et al., 2011). CRD-NRG1 serves as a key regulator
of myelination in the peripheral nervous system (Nave and Sal-
zer, 2006) but is not required for myelin assembly in the CNS
(Brinkmann et al., 2008), suggesting that it has distinct functions
in the brain.
Heterozygous disruption of CRD-NRG1 in mice results in def-
icits in glutamatergic and cholinergic neurotransmission from the
hippocampus to the amygdala (Jiang et al., 2013; Zhong et al.,
2008) and impaired short-term memory (Chen et al., 2008). Ge-
netic inactivation of ErbB4, the predominant neuronal NRG1 re-
ceptor in the brain, results in increased long-term potentiation
(LTP) (Pitcher et al., 2008) and blocked NRG1-mediated LTPs
suppression in hippocampal slice culture (Chen et al., 2010). In
addition, loss of ErbB4 in mice leads to impaired interneuron
development, reduced GABAergic neurotransmission (Del Pino
et al., 2013; Fazzari et al., 2010; Neddens and Buonanno,
2010), and enhanced limbic epileptogenesis (Li et al., 2012;
Tan et al., 2012), demonstrating an important role of ErbB4
signaling in the regulation of inhibitory cortical circuitry. In
‘‘gain-of-function’’ approaches, the treatment of cultured neu-
rons or brain slices with the soluble epidermal-growth-factor-
like domain of NRG1 was shown to induce transcription of
mRNAs encoding neurotransmitter receptors (Ozaki et al.,
1997); to modulate glutamatergic, GABAergic, cholinergic, and
dopaminergic neurotransmission (Gu et al., 2005; Kwon et al.,
2005; Ting et al., 2011; Woo et al., 2007); to suppress hippocam-
pal synaptic plasticity (Huang et al., 2000; Kwon et al., 2005;
Pitcher et al., 2011); and to promote dendritic spine growth
(Cahill et al., 2013). Recently, transgenic mice with forebrain-
specific overexpression of ‘‘soluble’’ immunoglobulin (Ig)-
domain-containing NRG1 (‘‘Ig-NRG1’’) have been reported to
display synaptic dysfunction and behavioral deficits (Yin et al.,
2013a). Collectively, these studies suggest that NRG1 functions
as a pleiotropic factor in the establishment and fine-tuning of
cortical circuitry. In addition, these data support the hypothesis
that both reduced and increased NRG1 signaling may interfere
with synaptic efficacy. However, the effect of elevated CRD-
NRG1 signaling has not been studied in vivo, and due to embry-
onic lethality of the Nrg1-null mutation (Meyer and Birchmeier,
1995), the consequences of a permanent loss of NRG1 on syn-
aptic functions have not been elucidated.
Here, we have modeled the loss of all NRG1 isoforms and
elevated CRD-NRG1 expression in conditional mouse mutants
and transgenic mice. Our data provide potential pathomechan-
isms for cortical disconnectivity in response to chronically
altered CRD-NRG1 signaling.
RESULTS
Hypoactivity and Impaired Fear-Conditioned Learning in
the Absence of NRG1
Postnatal recombination of a conditional (‘‘floxed’’)Nrg1 allele (Li
et al., 2002) in forebrain projection neurons using a CamKII-Cre
driver line (Minichiello et al., 1999) resulted in a 30%–75% reduc-
tion of NRG1 protein levels in homozygous floxed Nrg1 mutants
harboring the CamKII-Cre transgene (referred to as CK*Nrg1f/f),
depending on the cortical region analyzed (Figures 1A, S1A,
and S1B). Even at 18 months of age, we observed no signs of
neurodegeneration and inflammation in the hippocampus (Fig-
ure 1B) or white matter (Figure S1C) and no change in the levels
of PSD95, ErbB4, and several glutamate receptor subunits in
CK*Nrg1f/f mutants (Figures 1C, 1D, and S1D).
Next, we performed a behavioral analysis of CK*Nrg1f/f mu-
tants. We found no significant effects on the startle response
and prepulse inhibition (PPI) in CK*Nrg1f/f mutants (Figures
S1E and S1F; data not shown). However, CK*Nrg1f/f mutants
displayed hypoactivity in the open-field test at 3 months of age
(Figure 1E). Hypoactivity in CK*Nrg1f/f mutants was not associ-
ated with increased general anxiety in the open-field test (Fig-
ure S1G). Administration of the noncompetitive NMDA receptorCelantagonist MK-801 induces hyperactivity and serves as a phar-
macological model of psychosis (Deutsch et al., 1997). A single
dose of MK-801 (0.3 mg/kg) administered to control mice
(Nrg1f/+) at 3months (Figure 1F) and 12months of age (Figure 1H)
increased motor activity for more than 1 hr. In contrast,
CK*Nrg1f/fmutants at 3 to 4 months of age showed a strong ten-
dency for reduced MK-801-induced hyperactivity (Figure 1F). At
12months of age,CK*Nrg1f/fmutants were no longer hypoactive
in the open-field test (Figure 1G). However, MK-801-induced hy-
peractivity was significantly reduced in CK*Nrg1f/f mutants and
rapidly declined to baseline levels (Figure 1H). To examine the
performance in a hippocampus-dependent learning task, we
analyzed CK*Nrg1f/f mutants in a cued and contextual fear-con-
ditioning paradigm. CK*Nrg1f/f mutants showed a tendency for
reduced contextual fear conditioning at 3 to 4 months (Figure 1I)
and exhibited a reduced freezing response both to the context
and the auditory cue at 12 months of age (Figure 1J). Thus,
loss of NRG1 signaling results in progressive deficits in hippo-
campus-dependent learning.
Loss of NRG1 Signaling Disrupts Synaptic Plasticity and
Alters the Balance of Excitatory-Inhibitory
Neurotransmission in the Hippocampus
To address whether reduced fear-conditioned learning in
CK*Nrg1f/f mutants might result from impaired LTP, we tested
field excitatory postsynaptic potentials (fEPSPs) at the Schaffer
collateral (SC)-CA1 synapse of acute hippocampal slices from
18- to 20-month-old CK*Nrg1f/f mutant and Nrg1f/+ control
mice. No change in the input-output curve was observed (data
not shown), but paired-pulse facilitation was reduced in
CK*Nrg1f/f mutants (Figure 2A). Next, we induced synaptic
potentiation in CA1 by high-frequency stimulation (HFS) of the
SC. Short-term potentiation (STP) (1 min after HFS) was
reduced, and the magnitude of LTP remained depressed
60 min after induction in CK*Nrg1f/f mutants (Figure 2B). To
examine whether disrupted LTP was associated with changes
in synaptic transmission already at younger age, we performed
whole-cell patch-clamp recordings in CA1 pyramidal neurons.
In 3-month-old CK*Nrg1f/f mutants, the amplitude of sponta-
neous excitatory postsynaptic currents (sEPSCs) was
decreased (Figures 2C and 2D). Conversely, the amplitude of
spontaneous inhibitory postsynaptic currents (sIPSCs) was
increased (Figures 2F and 2G). Both sEPSC and sIPSC fre-
quency were unchanged (Figures 2C, 2E, 2F, and 2H). In addi-
tion, the amplitude and frequency of miniature EPSCs (mEPSCs)
were depressed in CK*Nrg1f/f mutants (Figures 2I–2K), whereas
mIPSC amplitude was enhanced (Figures 2L and 2M) and
mIPSC frequency was depressed (Figures 2L and 2N). In sum-
mary, postnatal NRG1 deficiency in projection neurons shifts
the balance of excitatory-inhibitory neurotransmission toward
enhanced inhibition and leads to reduced LTP in the hippocam-
pus at later stages.
Embryonic NRG1 Signaling Is Not Essential for
Interneuron Migration and the Formation of Inhibitory
Cortical Circuits
To identify NRG1 functions during the establishment of
neuronal circuits, we performed a subset of the abovel Reports 8, 1130–1145, August 21, 2014 ª2014 The Authors 1131
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Figure 1. Behavioral Deficits in Mouse
Mutants with a Postnatal Loss of NRG1 in
Cortical Projection Neurons
(A) Time course ofCre-mediated NRG1 elimination
in cortical projection neurons of CamKCre*Nrg1f/f
mutants. (Left) Western blot analysis of cortical
protein lysates from mutants (CK*Nrg1f/f) and
controls (Nrg1f/+; age 15 months). Arrowheads,
full-length CRD-NRG1 (140 kDa), Ig-NRG1
(95 kDa), and C-terminal processing product
(60 kDa). Asterisk, unspecific protein band.
(Right) Densitometric quantification of 140, 95, and
60 kDa NRG1 bands. Integrated density values
were normalized to b-tubulin (n = 3/genotype;
***p < 0.0001).
(B) Immunostaining of CK*Nrg1f/f mutants
(12 months) shows absence of markers of inflam-
matory astrogliosis (GFAP) and microgliosis
(MAC3) in the CA1 region (brackets). The scale
bars represent 50 mm and 10 mm (inset).
(C) Western blot analysis of hippocampal protein
lysates from CK*Nrg1f/f mutants (knockout [KO])
and Nrg1f/+ controls (con) at 15 months after MK-
801 treatment. ErbB4, ErbB4 receptor; GluR1,
AMPA receptor subunit 1; NR1, NR2B, NMDA re-
ceptor subunit 1 and 2B; nAch7, nicotinic acetyl-
choline receptor a7 subunit; PSD95, postsynaptic
density protein 95. b-tubulin was used as a loading
control.
(D) Densitometric quantification of integrated
density values normalized to b-tubulin (n = 3/ge-
notype).
(E) Reduced motor activity of CK*Nrg1f/f mutants
(n = 15) in the open-field test comparedwithNrg1f/+
controls (n = 10) at 3 months (*p < 0.05).
(F) Tendency for reduced responsiveness to MK-
801 in CK*Nrg1f/f mutants compared with Nrg1f/+
controls at 3 to 4 months. Motor activity in the
open field was measured as the distance traveled
during 4 min time intervals and expressed as
percentage relative to baseline activity obtained
individually before MK-801 treatment (single dose
at 0.3 mg/kg). Arrow indicates MK-801 injection
(CK*Nrg1f/f n = 9; Nrg1f/+ n = 6; effect of genotype,
p = 0.0678; two-way ANOVA for repeated mea-
sures).
(G) Unchanged motor activity of CK*Nrg1f/f mu-
tants (age 12 to 13 months) in the open-field test
(n = 9–13). n.s., not significant.
(H) Reduced MK-801-induced hyperactivity in
CK*Nrg1f/f mutants compared with Nrg1f/+ con-
trols at 12 to 13 months (n = 9–13; significant
effect of genotype, F(2, 696) = 5.43, *p < 0.05; sig-
nificant effect of time, F(29, 696) = 7.08, ***p <
0.0001; two-way ANOVA for repeated measures).
(I) Tendency for reduced contextual fear condi-
tioning in CK*Nrg1f/fmice in comparison to Nrg1f/+
controls at 3 to 4 months (n = 9–11; p = 0.0576).
Fear-conditioned learning is displayed as the
percentage of time mice show freezing behavior during a 2 min time period after re-exposure to context or cue (tone). Baseline: freezing during initial exposure to
context prior to cue exposure. Base cue: freezing during exposure to new context prior to cue re-exposure. FC, fear conditioning.
(J) Reduced contextual and cued fear conditioning in CK*Nrg1f/f mutant mice at 12 to 13 months (n = 9–12; *p < 0.05). Error bars represent SEM.experiments in Emx1-Cre*Nrg1f/f mutants (Emx*Nrg1f/f), in
which NRG1 is eliminated in projection neurons and glial cells
beginning at embryonic day (E) 10 (Figure 3A; Gorski et al.,1132 Cell Reports 8, 1130–1145, August 21, 2014 ª2014 The Author2002). Emx*Nrg1f/f mutants were born at the expected Mende-
lian frequency and survived into adulthood. Despite a reduction
of cortical NRG1 protein levels by 80% in Emx*Nrg1f/fs
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Figure 2. NRG1 Deficiency in Cortical Projection Neurons Disrupts Hippocampal Synaptic Plasticity and Increases Inhibitory Neurotrans-
mission
(A) Top, sample fEPSPs traces from CK*Nrg1f/f mutant and Nrg1f/+ control mice. Bottom, paired-pulse ratio (fEPSP slope second stimulus/fEPSP slope first
stimulus) at interstimulus intervals of 25–75 ms was reduced in CK*Nrg1f/f mutants (n = 12) in comparison to Nrg1f/+ controls (n = 11).
(B) Top, sample traces of responses before and after HFS. Bottom, LTP elicited byHFS (fEPSP slopes) forCK*Nrg1f/fmutants (n = 11) andNrg1f/+ controls (n = 12).
HFS application at time point 0. Both themagnitude of STP (maximal responses within 1min after HFS) and LTP (responses 50–60min after HFS) were reduced in
CK*Nrg1f/f mice.
(C) Representative sEPSC recordings from CA1 pyramidal neurons of a CK*Nrg1f/f mutant and Nrg1f/+ control.
(legend continued on next page)
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mutants (Figure 3B), gray and white matter structures appeared
to be normally developed (Figures S2A and S2C). In contrast to
ErbB4 mutants (Neddens and Buonanno, 2010), the number of
GAD67-positive cells in the hippocampus (Figures 3C and 3E)
and their cortical-layer-specific distribution (Figures 3D, 3F,
and S2D) were not altered in Emx*Nrg1f/f mutants at postnatal
day (P) 14.
Whole-cell patch-clamp recordings of CA1 pyramidal neu-
rons revealed changes in neurotransmission in 3-month-old
Emx*Nrg1f/f mutants similar to findings in CK*Nrg1f/f mutants.
The amplitude of sEPSCs was depressed (Figures 3G–3I),
whereas both sIPSC amplitude and frequency (***p < 0.001)
were increased in Emx*Nrg1f/fmutants (Figures 3J–3L). Similarly,
mEPSC amplitude was reduced (Figures 3M–3O) and mIPSC
amplitude enhanced in Emx*Nrg1f/f mutants (Figures 3P–3R).
These findings argue against an essential role for glial and pro-
jection neuron-derived NRG1 during interneuron migration and
the formation of inhibitory cortical circuits but support NRG1
functions in the fine tuning of excitatory and inhibitory neuro-
transmission in projection neurons.
Elevated CRD-NRG1 Expression Increases Inhibitory
Neurotransmission and Disrupts Synaptic Plasticity in
the Hippocampus
CRD-NRG1 is the most prominent NRG1 variant in the mature
cortex (Liu et al., 2011). To test the hypothesis that CRD-NRG1
serves as a signal for ErbB-receptor-mediated synaptic tuning,
we examined transgenic mice (Nrg1-tg) that express CRD-
NRG1 from the neuronal Thy1.2 promoter (Michailov et al.,
2004). Transgene expression was initiated around E16 (Fig-
ure S2B) and prominent in neocortex and hippocampus of the
adult brain (Figures 4A and 4B). CRD-NRG1 accumulated on
the surface of projection neurons but was absent from interneu-
rons, astrocytes, and oligodendrocytes (Figure 4C). Western blot
analysis revealed increased steady-state levels of phosphory-
lated ErbB4 receptor in the hippocampus of Nrg1-tg mice at 4
months of age (Figure 4D). Thus,Nrg1-tgmice model chronically
elevated CRD-NRG1 expression (derived from cortical projec-
tion neurons) and ErbB4 receptor hyperphosphorylation begin-
ning at late embryonic stages.
In the absence of markers of neurodegeneration and inflam-
mation (Figure S2C), we performed in vivo MRI and found that
lateral ventricular volume was reduced in Emx*Nrg1f/f mutants
and increased in Nrg1-tg mice, whereas total brain volume
was not changed at 12 months of age (Figures 4E–4G and
S3F). Ventricular volume was already increased in 6-month-old(D and E) Cumulative probability plots of sEPSC amplitude (D) and frequency (E)
(n = 8).
(F) Representative sIPSC recordings from CA1 pyramidal neurons of a CK*Nrg1f
(G andH) Cumulative probability plots of sIPSC amplitude (G) and frequency (H) in
mice.
(I) Representative mEPSC recordings from CA1 pyramidal neurons of a CK*Nrg1
(J and K) Cumulative probability plots of mEPSC amplitude (J) and frequency (K)
(n = 8).
(L) Representative mIPSC recordings from CA1 pyramidal neurons of a CK*Nrg1
(M and N) Cumulative probability plots of sIPSC amplitude (M) and frequency (N
(n = 10) mice. *p < 0.05; **p < 0.01; ***p < 0.001; Mann-Whitney U test.
1134 Cell Reports 8, 1130–1145, August 21, 2014 ª2014 The AuthorNrg1-tg mice (Figures S3C–S3E), but not at P14 (Figures S3A
and S3B), suggesting a young adult onset. Thus, ventricular
enlargement, a condition frequently observed in schizophrenia
patients, is associated with elevated CRD-NRG1 expression,
but not with NRG1 deficiency in our mouse models.
Next, we studied synaptic transmission in CA1 pyramidal neu-
rons of Nrg1-tgmice and wild-type littermate controls (wild-type
[WT]). Both sEPSC amplitude and frequency were unaltered in
Nrg1-tg mice (Figures 5A–5C). In contrast, sIPSC frequency
was almost doubled in Nrg1-tg mice (Figures 5D–5F). Similarly,
mEPSC amplitude and frequency were unaltered (Figures S4A
and S4B), whereas mIPSC frequency was enhanced in Nrg1-tg
mice (Figures 5G and 5H). When we examined LTP at the SC-
CA1 synapse, we observed no changes in the input-output curve
or paired-pulse facilitation (Figure S4C); however, both STP and
LTP were reduced in Nrg1-tg mice (Figure 5I). These findings
suggest that elevated CRD-NRG1 signaling shifts the excit-
atory-inhibitory synaptic balance in CA1 pyramidal neurons to-
ward enhanced inhibition, most likely due to increased synaptic
input from GABAergic interneurons and/or enhanced presynap-
tic GABA release.
To address whether impaired LTP was related to changes in
the molecular composition of cortical synapses, we prepared
cortical synaptosomes from Nrg1-tgmice, Emx*Nrg1f/f mutants,
and controls. Western blot analyses identified differences in the
synaptic levels of CRD-NRG1 in Nrg1-tg mice in comparison to
Emx*Nrg1f/f mutant mice, but protein levels for ErbB4, PSD95,
as well as GluN1 and GluN2B subunits of NMDA receptors
were not changed (Figures 5J and S5A), consistent with the un-
altered transcription of ErbB4 and various neurotransmitter re-
ceptors (Figures S5B–S5E). To obtain global protein expression
profiles from Nrg1-tg mice, we analyzed their proteome using a
label-free shotgun-liquid chromatography-mass spectrometry
(LC-MSE) approach. This resulted in the identification of 40
differentially expressed proteins in the hippocampus of 4-
month-old Nrg1-tg mice (see Table S1), including several that
play a role in functional and structural plasticity at glutamatergic
synapses (CaM kinase II a and b subunits, protein phosphatase
2B, and septin 6; Figure 5K). Next, we identified interaction net-
works and canonical pathways using the Ingenuity Pathways
KnowledgeBase (IPKB) (http://www.ingenuity.com). A signifi-
cant network showed interactions of the uploaded proteins
with a cluster of glutamate receptors (Figure 5L; Table S2). The
most significant canonical pathway was LTP (not shown; p <
0.001), consistent with our electrophysiological findings in
Nrg1-tg mice.in CA1 pyramidal neurons from CK*Nrg1f/f mutants (n = 6) and Nrg1f/+ controls
/f mutant and Nrg1f/+ control.
CA1 pyramidal neurons fromCK*Nrg1f/fmutant (n = 8) andNrg1f/+ control (n = 5)
f/f mutant and Nrg1f/+ control.
in CA1 pyramidal neurons from CK*Nrg1f/f mutants (n = 6) and Nrg1f/+ controls
f/f mutant and Nrg1f/+ control.
) in CA1 pyramidal neurons from CK*Nrg1f/f mutant (n = 9) and Nrg1f/+ control
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Abnormal Spine Growth and Reduced Numbers of
Parvalbumin-Expressing Interneurons in the Neocortex
of Nrg1-tg Mice
We next addressed whether increased CRD-NRG1 expression
also affects neocortical network functions. To visualize den-
drites and spines, we crossbred Nrg1-tg mice with a Thy1.2-
YFP transgenic mouse line, which expresses yellow fluorescent
protein (YFP) in a subset of projection neurons in cortical layer V
(Hirrlinger et al., 2005). In vivo imaging of dendrites in Thy1.2-
YFP*Nrg1-tg double transgenic mice (YFP*Nrg1) and Thy1.2-
YFP controls (con) at 3 to 4 months of age by two-photon
laser-scanning microscopy (2P-LSM) revealed no difference in
the number of primary dendrites (con: 7.24 ± 0.17; YFP*Nrg1:
7.18 ± 0.09; Figures 6A, 6B, and S6C) and branch points of api-
cal dendrites up to the marginal zone (MZ) (con: 4.03 ± 0.32;
YFP*Nrg1: 4.23 ± 0.22; Figures 6A and 6C). Next, we applied
stimulated emission depletion (STED) nanoscopy through a cra-
nial window above the somatosensory cortex to resolve struc-
tural details of apical dendrites and spines of layer V projection
neurons in the MZ of live mice (Berning et al., 2012). Total spine
frequency was not changed in YFP*Nrg1 mice (con: 0.35 ±
0.02 mm1, YFP*Nrg1: 0.36 ± 0.02 mm1; Figure 6D). Using
in vivo STED nanoscopy, we observed several previously
defined morphological spine classes (‘‘mushroom,’’ ‘‘cup,’’
‘‘stubby,’’ ‘‘filopodium,’’ and ‘‘bifurcated’’; Hering and Sheng,
2001; Trommald et al., 1996) and determined their frequency
(Figures S6A and S6B). In YFP*Nrg1 mice, the frequency of
bifurcated spines was increased more than 3-fold (con: set as
1 ± 0.31; YFP*Nrg1: 3.74 ± 0.82; p < 0.01), and we observed a
concomitant, albeit not significant, reduction in the frequency
of other spine types, except for filopodium-like spines (Fig-
ure 6E). Furthermore, the necks of mushroom and cup spines
were longer in YFP*Nrg1 mice compared with controls (mush-
room: con: 0.98 ± 0.04 mm, YFP*Nrg1: 1.2 ± 0.05 mm,Figure 3. Embryonic NRG1 Signaling Is Not Essential for Interneurona
(A) Embryonic NRG1 elimination using the Emx1-Cre driver line overlaps with n
section from an Emx-Cre*Rosa26lacZ double-transgenic mouse (P46) shows Cre
glial cells. The scale bar represents 1 mm.
(B) (Left) Western blot analysis of cortical protein extracts from Emx*Nrg1f/f muta
NRG1 protein. Asterisk, unspecific protein band. (Right) Densitometric quantifi
normalized to b-tubulin (n = 3/genotype; **p < 0.01).
(C) Normal numbers and cortical positions of GAD67+ interneurons in Emx*Nrg1f/fm
sections from Emx*Nrg1f/fmutants and controls (Nrg1f/f andWT) at P14. Higher ma
scale bars represent 500 mm and 50 mm (CA1 region).
(D) Immunostaining for NeuN and GAD67 (higher magnification of boxed area f in
somatosensory cortex of Emx*Nrg1f/f mutants in comparison to controls (Nrg1f/f
(E) Quantification of GAD67+ interneurons in the hippocampus (marked area e in
(F) Quantification of GAD67+ interneurons in the neocortex (boxed area f in C) of E
represent SEM.
(G) Representative sEPSC recordings of CA1 pyramidal neurons from Emx*NRG
(H and I) Cumulative probability plots of sEPSCamplitude (H) and frequency (I) inCA
(J) Representative sIPSC recordings of pyramidal neurons from Emx*NRG1f/f mu
(K and L) Cumulative probability plots of sIPSC amplitude (K) and frequency (L) in p
(M) Representative mEPSC recordings of pyramidal neurons from Emx*NRG1f/f m
(N and O) Cumulative probability plots of mEPSC amplitude (N) and frequency (O
(n = 5).
(P) Representative mIPSC recordings of pyramidal neurons from Emx*NRG1f/f m
(Q and R) Cumulative probability plots of mIPSC amplitude (Q) and frequency (R
(n = 10).
*p < 0.05; **p < 0.01; ***p < 0.001; Mann–Whitney U test.
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0.02 mm, p < 0.05; Figure 6F).
To assess functional consequences of the selective increase
of bifurcated spines, we performed recordings in cortical layer
V neurons using acute cortical slices prepared from the same
neocortical area that was used for in vivo STED nanoscopy.
Both mEPSC frequency and amplitude were increased in YFP-
Nrg1 mice (Figures 6G–6I). In addition, analysis of mEPSC ki-
netics revealed that the mean slope of onset was increased
and the distribution shifted toward events with faster onset in
YFP-Nrg1 mice (con: 12.77 ± 0.23 pA/ms; YFP-Nrg1: 18.24 ±
0.26 pA/ms; Figure 6J). Given that perisomatic events display
faster onset in comparison to dendritic events (Miles et al.,
1996), these data suggest that changes in spine structure may
reduce effective glutamatergic synaptic transmission by chang-
ing the NMDA/AMPA ratio or postsynaptic receptor kinetics at
distal sites.
CRD-NRG1 serves as a permissive signal for the migration of
cortical interneurons in vitro (Flames et al., 2004), suggesting that
interneuron migration could be affected in Nrg1-tg mice. Immu-
nostaining for GAD67 and parvalbumin (PV) at P14 revealed
minor changes in the cortical distribution of GAD67+ cells in
Nrg1-tg mice (Figure 7A), but not in the total number of neocor-
tical (Figures 7A and 7B) and hippocampal interneurons (Figures
S6D and S6E). To visualize PV+ interneurons in vivo, we cross-
bred Nrg1-tg mice with PV-GFP transgenic mice that express
GFP under control of regulatory sequences from the PV gene
(Meyer et al., 2002). 2P-LSM in vivo imaging of PV-GFP*Nrg1-
tg double transgenic mice at 3 months of age revealed a lower
number of GFP+ cells in cortical layers II/III and V and a reduction
in the total number of GFP+ cells by 20% compared with PV-
GFP controls (Figures 7C and 7D). We observed a similar reduc-
tion of GFP+ cells in a second mouse line, which expresses
epitope-tagged CRD-NRG1 (Velanac et al., 2012). PV+l Migration
etwork integration of cortical interneurons (IN). X-gal histochemistry on brain
-mediated recombination of lacZ reporter in forebrain projection neurons and
nts (KO) and Nrg1f/+ con at 4 months. Arrowheads, full-length and processed
cation of NRG1 isoforms (140 and 95 kDa). Integrated density values were
utants during cortical maturation. Immunostaining for GAD67 on coronal brain
gnifications (right) show the hippocampal CA1 region (boxed in overviews). The
C) reveals normal layering (I–VI, cortical layers) and interneuron positions in the
and WT). Bregma, 1.7; scale bars, 50 mm (NeuN); 100 mm (GAD67).
C) of Emx*Nrg1f/f mutants and controls (Nrg1f/f and WT). n = 6/genotype.
mx*NRG1f/f mutants and controls (Nrg1f/f andWT). n = 6/genotype. Error bars
1f/f mutants and Nrg1f/+ controls.
1 pyramidal neurons fromEmx*Nrg1f/fmutants (n = 9) andNrg1f/+ controls (n= 8).
tants and Nrg1f/+ controls.
yramidal neurons from Emx*Nrg1f/fmutants (n = 6) andNrg1f/+ controls (n = 7).
utants and Nrg1f/+ controls.
) in pyramidal neurons from Emx*Nrg1f/f mutants (n = 8) and Nrg1f/+ controls
utants and Nrg1f/+ controls.
) in pyramidal neurons from Emx*Nrg1f/f mutants (n = 10) and Nrg1f/+ controls
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Figure 4. Elevated CRD-NRG1 Expression
Causes Ventricular Enlargement
(A) Neuronal CRD-NRG1 overexpression in trans-
genic mice. Structure of the Thy1.2 transgene
cassette (brown box, CRD-NRG1 cDNA; white
boxes, exons I-IV of the Thy1.2 gene). Immuno-
staining for NRG1 on coronal brain sections from
wild-type (WT) and CRD-NRG1 transgenic mice
(Nrg1-tg) at 12 months. Note enlarged lateral
ventricle in Nrg1-tg brain.
(B) Top, CRD-NRG1 expression in hippocampal
pyramidal neurons and granule cells of Nrg1-tg
mice (magnification of boxed area in A). Bottom,
CRD-NRG1 is present in callosal axons (magnifi-
cation of boxed area at the top). cc, corpus cal-
losum; DG, dentate gyrus; sml, stratum molec-
ulare; so, stratum oriens; sp, stratum pyramidale;
sr, stratum radiatum; wm, white matter. The scale
bars represent 125 mm (top) and 60 mm (bottom).
(C) Projection neuron-specific CRD-NRG1 over-
expression. Confocal images of coronal brain
sections after fluorescent immunostaining for
NRG1 (green) and markers (red) for projection
neurons (MAP2), interneurons (GAD67), astrocytes
(GFAP), and oligodendrocytes (CNP) in the so-
matosensory cortex ofNrg1-tgmice. The scale bar
represents 20 mm.
(D) Chronic ErbB4 hyperphosphorylation in the
hippocampus of Nrg1-tg mice. Western blot
analysis of hippocampal protein lysates from
Nrg1-tg mice (tg) and WT (4 months). Densito-
metric quantification of phosphorylated ErbB4
bands. Integrated density values were normalized
to b-actin (n = 3/genotype; *p < 0.05; two-tailed
t test).
(E) Enlarged lateral ventricles in Nrg1-tg mice (ar-
rowheads) in comparison to Emx*Nrg1f/f mutants
andWTmice (12 to 13 months). T1-weighted MRI.
(F) MRI-based volumetric analysis reveals no
changes in total brain volume (cm3) of Emx*Nrg1f/f
mutants and Nrg1-tg in comparison to WT mice
(n = 5 per genotype; Mann-Whitney U test).
(G) Ventricular volume (in percent of total brain
volume) is reduced in Emx*Nrg1f/f mutants and
increased in Nrg1-tg in comparison to WT mice
(WT, Emx*Nrg1f/f, n = 5; Nrg1-tg, n = 4; **p < 0.01,
WT versus Emx*Nrg1f/f; p < 0.05, WT versus
Nrg1-tg and Emx*f/f versus Nrg1-tg; Mann-Whit-
ney U test).interneurons provide perisomatic inhibition to projection neu-
rons. Electrophysiological recordings in acute cortical slices
(as above) revealed a moderate increase in mIPSC frequency
in layer V projection neurons (Figures 7E–7G). Analysis of mIPSC
kinetics showed a shift toward events with slower onset, such
that the mean slope of event onset was reduced in Nrg1-tgCell Reports 8, 1130–1145,mice (con: 27.9 ± 0.34 pA/ms; Nrg1-tg:
22.8 ± 0.18 pA/ms; Figure 7H), consistent
with a reduction of PV+ interneuron-medi-
ated perisomatic events in layer V.
Finally, we tested whether increased
CRD-NRG1 expression causes behavioraldysfunctions. The neuromuscular junction in Nrg1-tg mice is
severely compromised (W.J. Thompson, personal communica-
tion), which renders these mice less suitable for behavioral anal-
ysis. Therefore, we examined amouse line (HA-Nrg1-tg), in which
hemagglutinin (HA) epitope-tagged CRD-NRG1 is expressed un-
der control of the same Thy1.2 cassette as in Nrg1-tg miceAugust 21, 2014 ª2014 The Authors 1137
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(Figure S7A; Velanac et al., 2012). Similar to Nrg1-tg mice, we
observed HA-CRD-NRG1 expression on the surface of cortical
projection neurons, ventricular enlargement, and a reduced num-
ber of GFP+ interneurons inHA-Nrg1-tgmice (Figures S7B–S7D).
At 2 to 3months of age, the distance traveled in the open-field test
was not altered in HA-Nrg1-tgmice (m; males:WT: 44.17 ± 1.93,
HA-Nrg1-tg: 42.49 ± 2.21; females: WT: 42.92 ± 1.41, HA-Nrg1-
tg: 42.31 ± 2.32; Figure S7E). However, HA-Nrg1-tg mice spent
less time in the center of the open-field arena (males: WT:
24.16% ± 3.77%, HA-Nrg1-tg: 10.61% ± 2.13%; females: WT:
21.11% ± 2.11%, HA-Nrg1-tg: 6.87% ± 2.41%; Figure 7I) and
male mice displayed more frequent defecation (males: WT:
1.778 ± 0.586; HA-Nrg1-tg: 4.13 ± 0.72; Figure S7F), in line with
increased anxiety. In addition, HA-Nrg1-tgmice performed fewer
rearings (males: WT: 56.28 ± 3.86, HA-Nrg1-tg: 39 ± 4.64;
females: WT: 48.5 ± 2.92, HA-Nrg1-tg: 31.1 ± 4.53; Figure 7J),
suggesting diminished exploratory behavior. Assessment of
sensorimotor gating (Figures 7K and 7L) showed a profound PPI
deficit in HA-Nrg1-tg mice. Moreover, they displayed an
increased startle response (males:WT: 184.9 ± 39.56, HA-Nrg1-
tg: 344.9 ± 42.07; females: WT: 71.43 ± 12.51, HA-Nrg1-tg:
280.2 ± 19.24; Figure S7G). In summary, our findings in loss-
and gain-of-function mouse mutants support a bell-shaped
model of NRG1-mediated synaptic functions (Figure 8), according
to which an optimal level of NRG1 signaling is required for
balanced synaptic transmission and plasticity in the cortex.
DISCUSSION
In this study, we carried out a systematic characterization of con-
ditional Nrg1 mutants and Nrg1-tg mice with increased CRD-
NRG1 expression. The main findings of this study are as follows:
(1) Both NRG1 deficiency and increased CRD-NRG1 expres-
sion led to disrupted hippocampal plasticity and imbalanced
excitatory and inhibitory neurotransmission. (2) Elevated CRD-
NRG1 expression resulted in ventricular enlargement and
abnormal spine growth. (3) Morphological changes in Nrg1-tg
mice were accompanied by increased anxiety levels and disrup-
ted sensorimotor gating.
Our analysis of CK*Nrg1f/f mutants has shown that NRG1 is
required for hippocampal LTP. This finding contrasts with aFigure 5. Elevated CRD-NRG1 Expression Increases Inhibitory Neurot
(A) Representative sEPSC recordings from CA1 pyramidal neurons in WT and N
(B and C) Cumulative probability plots of sEPSC amplitude (B) and frequency (C
(D) Representative sIPSC recordings from pyramidal neurons in WT and Nrg1-tg
(E and F) Cumulative probability plots of sIPSC amplitude (E) and frequency (F) i
(G and H) Cumulative probability plots of mIPSC amplitude (G) and frequency (H)
0.01; ***p < 0.001; Mann-Whitney U test.
(I) Sample traces of responses (top) before and after HFS and LTP elicited by HFS
15). Both STP and LTP were significantly reduced in Nrg1-tg mice (**p < 0.01; S
(J) Western blot analysis of proteins (Triton X-100 soluble and insoluble fraction of
Nrg1-tg, and WT mice (age 15–18 months). Levels of ErbB4, NR1, NR2B, phosp
b-tubulin cosediments in all fractions as a contaminant.
(K) LC-MSE identification of differentially expressed proteins in the hippocampus
code; ECM, extracellular matrix; Pep, number of peptides identified for each pro
(L) Accession codes for altered proteins (see Table S1) were uploaded into the
nificant network (score 15), which showed interactions of the uploaded proteins w
activated protein kinase 1 (MAPK1) kinases are highlighted in blue. A cluster of fi
indicated.
Celstudy in heterozygous Nrg1 mutants, in which hippocampal
LTP was increased (Shamir et al., 2012). These discrepancies
most likely reflect differences in the spatiotemporal profile of
Nrg1 deletion in conventional heterozygous mutants in compar-
ison to conditional Nrg1-null mutants and point to the modula-
tory role of distinct levels of NRG1 during synaptic transmission.
In addition, loss of NRG1 in CK*Nrg1f/f and Emx*Nrg1f/f mutant
mice consistently resulted in increased IPSC amplitudes in hip-
pocampal pyramidal neurons. We conclude that expression or
responsiveness of postsynaptic GABA receptors on pyramidal
neurons is enhanced in the absence of NRG1 signaling. Our find-
ings in Nrg1 conditional mutants contrast with those in ErbB4-
null mutants, in which inhibitory circuits are compromised (Del
Pino et al., 2013; Fazzari et al., 2010; Neddens and Buonanno,
2010; Wen et al., 2010) and LTP is enhanced (Chen et al.,
2010; Pitcher et al., 2008; Shamir et al., 2012). Thus, we suggest
that NRG1 is an important, but not the sole, mediator of ErbB4
signaling in the brain and that ErbB4 integrates signals frommul-
tiple ligands, such as neuregulin 2 (Carraway et al., 1997), during
the regulation of inhibitory circuits.
Similar to NRG1deficiency, elevatedCRD-NRG1expression in
projection neurons disrupted hippocampal LTP. In addition, we
observed increased IPSC frequency and abnormal spine growth
in pyramidal cells of CRD-NRG1 transgenic mice. These effects
appeared to be specific for CRD-NRG1 as overexpression of
Ig-domain-containing NRG1 (Ig-NRG1 or NRG1 type I) in trans-
genic mice using the same Thy1.2 promoter led to impaired
gamma oscillation, whereas LTP formation was not affected
(Deakin et al., 2012). A distinct transgenic mouse line with fore-
brain-specific overexpression of Ig-NRG1 shows reduced
mEPSC frequency and mIPSC amplitudes but unaltered mIPSC
frequency (Yin et al., 2013a). These data suggest that CRD-
NRG1, mainly acting via juxtacrine signaling, and Ig-NRG1,
serving as a soluble ligand in paracrine signaling, provide distinct
functions in the modulation of excitatory and inhibitory neuro-
transmission. Together, our data demonstrate an imbalance in
the excitatory/inhibitory (E/I) ratio toward pronounced inhibition
in conditional Nrg1 mutants and CRD-NRG1 transgenic mice.
We speculate that alterations in the E/I ratio in response to altered
NRG1 signaling could lead to deficits in cortical synchronization,
as implicated in schizophrenia (Uhlhaas and Singer, 2010).ransmission and Disrupts Hippocampal Plasticity
rg1-tg mice (3 to 4 months).
) in pyramidal neurons from Nrg1-tg mice (n = 15) compared with WT (n = 10).
mice.
n pyramidal neurons from WT (n = 9) and NRG1-tg mice (n = 16).
in pyramidal neurons fromWT (n = 8) and NRG1-tgmice (n = 9). *p < 0.05; **p <
. fEPSP slopes from Nrg1-tgmice (n = 22) were in comparison toWTmice (n =
tudent’s t test).
synaptosomal lysates) prepared from cerebral cortices of Emx*Nrg1f/fmutant,
horylated NR2B (pNR2B), and PSD95 were unaltered in all genotypes. Note:
of Nrg1-tg (n = 10) in comparison toWT (n = 10) mice. Acc, UniProt accession
tein; Ratio, Nrg1-tg/WT for each protein; Wilco, Wilcoxon test.
Ingenuity Pathways KnowledgeBase (IPKB). This led to identification of a sig-
ith other proteins in the IPKB (see Table S2). CAMK2A, CAMK2B, andmitogen-
ve glutamate receptors predicted to interact with the uploaded proteins is also
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Figure 6. Abnormal SpineGrowth inNrg1-tg
Mice
(A) 2P-LSM imaging of cortical layer V projection
neurons. Fluorescent image stacks were recorded
in Thy1.2-YFP*Nrg1-tg (YFP-Nrg1) and Thy1.2-
eYFP (con) mice at 3 to 4months. 3D volume of the
somatosensory cortex (bregma 2) from the
marginal zone (MZ) to layer V, rendered from
fluorescent image stacks. Box and bracket indi-
cate areas used for quantification in (B) and (C).
The scale bar represents 40 mm.
(B) The number of primary dendrites (quantified in
boxed area in A) was not altered in YFP*Nrg1
compared with control mice (n = 10 neurons/
mouse; n = 7 mice/genotype).
(C) The number of apical dendrite branch points
(from cell soma in layer V to the MZ, indicated by
bracket in A) was not altered in YFP*NRG1 mice
compared with control mice (n = 10 neurons/
mouse; n = 7 mice/genotype).
(D) In vivo STED nanoscopy of dendrites in the MZ
derived from cortical layer V projection neurons of
a con and a YFP*Nrg1 mouse. A bifurcated-type
spine (boxed) is shown at higher magnification.
The scale bar represents 2 mm.
(E) Relative frequency of spine classes (controls
set as 1) in the MZ of YFP-Nrg1 mice and controls
(30 dendrites per mouse; con, n = 4 mice; YFP-
Nrg1, n = 3, **p < 0.01; one way ANOVA, post hoc
Tukey’s test). fp, filopodium; mr, mushroom.
(F) Length (mm) of spine neck (for mushroom, cup,
and bifurcated spines) or entire spine (stubby and
filopodium). Necks of mushroom- and cup-like
spines were longer in YFP-Nrg1 mice (30 den-
drites/mouse;con, n =4mice;YFP-Nrg1, n =3; *p<
0.05; **p < 0.01; one-way ANOVA; post hoc Tu-
key’s test). Error bars represent SEM.
(G) Representative recordings of glutamatergic
mEPSCs from YFP+ projection neurons in cortical
layer V of control and YFP-Nrg1 mice.
(H and I) Cumulative probabilities of mEPSC fre-
quencies (H) and amplitudes (I) in YFP+ neurons
from control (n = 12) and YFP-Nrg1 (n = 13) mice.
**p < 0.01; ***p < 0.001; Mann-Whitney U test.
(J) Onset kinetics expressed as normalized histo-
grams of rise slopes (peak amplitude in pA over
time of onset in ms) of glutamatergic mEPSCs.
Mean values and the significance of onset kinetics
are indicated by squares positioned relative to the
x axis. **p < 0.01; Mann-Whitney U test.Based on the phenotypic profile of CRD-NRG1 overexpress-
ing mice, we suggest that human NRG1 risk haplotypes exert a
gain-of-function effect. This hypothesis is supported by the
finding that the schizophrenia risk haplotype HapICE is associ-
ated with increased CRD-NRG1 expression in the prefrontal cor-
tex (Weickert et al., 2012). In addition, elevated CRD-NRG1
expression induced chronic ErbB4 hyperphosphorylation in the
cortex of CRD-NRG1 transgenic mice, consistent with findings
in postmortem brain from schizophrenia patients (Hahn et al.,
2006). We propose that elevated CRD-NRG1 signaling impairs
synaptic plasticity via twomechanisms. First, it alters the cortical
E/I ratio. Specifically, we hypothesize that increased juxtacrine
signaling by CRD-NRG1 during development hyperstimulates1140 Cell Reports 8, 1130–1145, August 21, 2014 ª2014 The AuthorErbB4 receptors in PV+ interneurons, which increases feed-
forward inhibition by promoting the formation of GABAergic
presynaptic terminals on pyramidal neurons, as indicated by
elevated IPSC frequency. Increased feedforward inhibition could
compromise LTP formation. Second, it induces abnormal spine
growth. Elevated expression levels of CRD-NRG1 result in its
accumulation in the somatodendritic compartment of pyramidal
neurons. This could initiate abnormal backsignaling, such as
aberrant interactions of the C-terminal domain of NRG1 with
LIM kinase 1 (Wang et al., 1998; Yin et al., 2013a), a major regu-
lator of spine growth (Mizuno, 2013). Whereas we favor this
model, ErbB4 expressed in projection neurons and interneurons
was shown to regulate spine growth (Cooper and Koleske, 2014;s
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Figure 8. Bell-Shaped Model of NRG1-
Mediated Signaling in the Cortex
(A) Middle, sites of possible NRG1/ErbB4 in-
teractions in a simple microcircuit of the hippo-
campal CA1 region in wild-type. (1) Excitatory
CA3/CA1 (Schaffer collateral) synapse. (2) Excit-
atory pyramidal cell synapse on inhibitory (PV+)
basket cell (BC). (3) Inhibitory BC synapse on py-
ramidal cell. Question mark indicates uncertain
ErbB4 expression in pyramidal cells. Left, absence
of pyramidal cell-derived NRG1 signaling
(CK*Nrg1f/f mutant mice) leads to LTP impairment
at the CA1/CA3 synapse and increased IPSC
amplitudes, consistent with elevated expression/
function of GABA receptors. Right, CRD-NRG1
overexpression in pyramidal cells (Nrg1-tg mice)
promotes ErbB4 hyperphosphorylation and inhib-
itory synapse formation/function in BC (as indi-
cated by increased IPSC frequency) and leads to
impaired LTP at the CA1/CA3 synapse and
abnormal spine growth. LTP and spine defects
may result, at least in part, from somatodendritic
CRD-NRG1 accumulation and aberrant ‘‘back-
signaling’’ (red flash), partly independent from
ErbB4.
(B) Both chronically reduced and increased levels
of NRG1 signaling cause enhanced inhibitory
synaptic strength and reduced excitatory synaptic
strength, leading to a dysbalanced E/I ratio and
impaired hippocampal LTP.Del Pino et al., 2013; Yin et al., 2013b). Thus, abnormal spine
morphology could directly result from chronic hyperstimulation
of ErbB4 receptors. In summary, our data support the hypothesis
that abnormal spine growth, observed in schizophrenia patients
(Penzes et al., 2011), could be induced by hyperstimulated CRD-
NRG1 signaling.
Ventricular enlargement is the most-replicated endopheno-
type in schizophrenia, and variants of the NRG1 gene are asso-
ciated with increased lateral ventricle volume in schizophrenia
patients (Mata et al., 2009). We observed reduced ventricularFigure 7. Disturbed Inhibitory Circuitry, Anxiety-like Behavior, and Red
(A) (Left) Immunostaining for GAD67 on coronal brain sections fromWT and Nrg1-
100 mm. (Right) Quantification of GAD67+ interneurons (n = 6/genotype; *p < 0.0
(B) (Left) Immunostaining for PV as in (A). The scale bars represent 100 mm. (Righ
Mann-Whitney U test).
(C) 2P-LSM of PV-GFP*Nrg1-tg and PV-GFP control mice. Depicted are 3D projec
2 mm stack interval) from the MZ to layer V.
(D) Quantification of GFP+ interneurons in layers I–V from 2P-LSM live-imaging st
n = 6; PV-GFP, n = 5; *p < 0.05; Student’s t test.
(E) Representative recordings of GABAergic mIPSCs from YFP+ projection neuro
(F and G) Cumulative probabilities of mIPSC frequencies (F) and amplitudes (G)
(H) Onset kinetics expressed as normalized histograms of rise slopes (peak amplit
significance of onset kinetics are indicated by squares positioned relative to the
(I) HA-Nrg1-tg mice (age 2 to 3 months) spent less time in the center of the open
(J) HA-Nrg1-tg mice performed less rearings than WT in the open-field test.
(K and L) Reduced PPI inmale (K) and female (L)HA-Nrg1-tgmice.Males: effect of
F(1,24) = 16.09; ***p < 0.001; two-way ANOVA; Bonferroni posttest. (I–L):WT: males
bars represent SEM.
1142 Cell Reports 8, 1130–1145, August 21, 2014 ª2014 The Authorsize in Emx*Nrg1f/f mutants but enlarged lateral ventricles in
Nrg1-tg mice. Ventricular size is not affected in Ig-NRG1 trans-
genic mice (P. Harrison, personal communication). These find-
ings suggest a specific role of CRD-NRG1 in the regulation of
ventricular volume. Thus, chronically increased CRD-NRG1
expression could represent a risk factor for ventricular enlarge-
ment observed in schizophrenia patients.
In summary, our in vivo data demonstrate that both chroni-
cally reduced and increased NRG1 signaling interferes with
balanced neurotransmission and synaptic plasticity. Ouruced PPI in Nrg1-tg Mice
tg mice at P14 (somatosensory cortex; bregma1.7). The scale bars represent
5, Mann-Whitney U test). I–VI, cortical layers; WM, white matter.
t) Quantification of PV+ interneurons across all cortical layers (n = 6/genotype;
tions-rendered live-imaging stacks of a cortical column (2503 2503 500 mm3;
acks. Note that parts of layers V and VI could not be imaged. PV-GFP*Nrg1-tg,
ns in layer V of Thy1.2-YFP*Nrg1-tg (YFP-Nrg1) and Thy1.2-YFP (con) mice.
in YFP+ neurons from YFP-Nrg1 (n = 17) and control (n = 15) mice.
ude in pA over time to onset in ms) of GABAergic mIPSCs. Mean values and the
x axis. *p < 0.05; Mann-Whitney U test.
-field arena when compared with WT.
genotype F(1,32) = 4.31; *p < 0.05 for prepulse 70 dB; females: effect of genotype
, n = 18; females, n = 18;HA-Nrg1-tgmice: males, n = 16; females, n = 10. Error
s
findings extend an ‘‘inverted U’’ model of NRG1 signaling (Role
and Talmage, 2007), and we propose a bell-shaped model,
according to which an ‘‘optimal’’ level of NRG1 is required for
the establishment, refinement, and ‘‘homeostasis’’ of synaptic
neurotransmission. Although chronically reduced NRG1 sig-
naling in the brain impairs synaptic functions, our data suggest
that it is chronically increased CRD-NRG1 signaling that pheno-
copies several endophenotypes described for schizophrenia
patients. Thus, CRD-NRG1 transgenic mice could provide a
robust preclinical model for further studies of schizophrenia
and to facilitate the discovery and development of treatment
strategies.
EXPERIMENTAL PROCEDURES
Transgenic and Mutant Mice
The generation and genotyping of conditional null mutants of Nrg1 (Li et al.,
2002) and transgenic lines CRD-NRG1 (Michailov et al., 2004), HA-CRD-
NRG1 (Velanac et al., 2012), PV-GFP (Meyer et al., 2002), Emx1-Cre (Gorski
et al., 2002), and CamKIIa-Cre (Minichiello et al., 1999) has been described.
Primer sequences are available upon request. All animal experiments were
carried out in compliance with approved animal policies of the Max Planck
Institute of Experimental Medicine.
RNA Analysis
Total RNA was extracted using Qiazol Reagent (QIAGEN). cDNA was synthe-
sized from total RNA using randomnonamer primers and Superscript III RNase
H reverse transcriptase (Invitrogen). Quantitative real-time PCR was carried
out using the ABI Prism 7700 SequenceDetection System as described (Brink-
mann et al., 2008) and analyzed with 7500 Fast System SDS software version
1.3 (Applied Biosystems) and GraphPad Prism 5.0. PCR primer sequences are
available upon request.
Protein Analysis
Brain tissue was homogenized in sucrose or radioimmunoprecipitation assay
buffer with protease inhibitors (Complete tablets; Roche). For western blotting,
5–50 mg of protein lysate was size separated on 8% SDS-polyacrylamide gels
and blotted onto polyvinylidene fluoride membranes (Hybond-P; Invitrogen)
according to manufacturer’s instructions. Membranes were incubated with
primary antibodies as described in Supplemental Experimental Procedures.
The densitometric analysis of scanned enhanced chemiluminescence films
was carried out using ImageJ and GraphPad Prism 5.0. Data are displayed
as SEM, and statistical significance was tested using a Mann-Whitney U test.
Synaptosomes and Synaptic Plasma Membrane Preparation
Synaptosomes were isolated by a sucrose density gradient technique (Dodd
et al., 1981) modified to isolate synaptosomes from small quantities of starting
material (detailed in Supplemental Experimental Procedures). Synaptosomes
were fractionated into Triton X-100 soluble (synaptic membranes) and insol-
uble (mainly postsynaptic density proteins) fractions by ultracentrifugation
(Mizoguchi et al., 1989). The Triton X-100 insoluble fraction was solubilized us-
ing 2% SDS buffer. Analysis was performed using SDS-PAGE and western
blotting as described above and in Supplemental Experimental Procedures.
Proteomics
Proteins were extracted from hippocampal tissue, followed by separation on
SDS-polyacrylamide gels and enzymatic digestion with trypsin. Resulting pep-
tideswere analyzed on aWaters quadrupole time-of-flight Premier mass spec-
trometer as described (Martins-de-Souza et al., 2007). Wilcoxon signed-rank
tests were used to determine statistical significance (p < 0.05).
Histology and Immunostaining
Free-floating vibratome (40–50 mm) or paraffin sections (5 mm) were incubated
overnight with primary antibodies as described in Supplemental Experimental
Procedures. Sections were incubated with secondary antibodies Cy2Cel(1:10,000; Jackson ImmunoResearch), Cy3 (1:10,000; Jackson ImmunoRe-
search), Alexa 488 and Alexa Fluor 555 (1:2,000; Invitrogen) for 1 hr at room
temperature. For the analysis of neurodegenerative changes, paraplast-
embedded sections (5–7 mm)were stained with hematoxylin and eosin staining
(Merck) and Cresyl Violet. Digital images were obtained using 510-meta LSM
and Axiophot (Zeiss) and DMRXA (Leica) microscopes. All images were pro-
cessed with ImageJ.
Electrophysiology
Transverse slices (300 mm) were cut from mouse brain (10–12 weeks old) and
transferred to a recording chamber filled with artificial cerebrospinal fluid. Field
recording data were digitized by DigiData 1322A and analyzed using Clampfit
10.0 (Molecular Devices). During whole-cell patch recordings, sIPSCs were re-
corded at a holding potential of 70 mV in the presence of 10 mM 6-cyano-7-
nitroquinoxaline-2,3-dione and 40 mM 2-amino-5-phosphonopentanoic acid;
sEPSCs were recorded in the presence of 5 mM strychnine and 5 mM bicucul-
line. For mIPSC and mEPSC recording, 0.5 mM tetrodotoxin was added to the
bath solution. Data acquisition and analysis was carried out using pClamp 10.0
(Molecular Devices), MiniAnalysis (SynaptoSoft), and Prism 4 (GraphPad). Sta-
tistical significance was evaluated using a two-tailed unpaired Student’s t test
withWelch’s correction or aMann-WhitneyU test. Significance level was set to
p < 0.05, and values are displayed as SEM. For details, see the Supplemental
Experimental Procedures.
MRI and Volumetry
Mice were anesthetized with 5% isofluorane, intubated, and kept under anes-
thesia with 1%–1.5% isofluorane in oxygen and ambient air (1:1.5). MRI was
performed at a field strength of 2.35 T (Bruker Biospin MRI) using a T1-
weighted 3D FLASH sequence as described (Natt et al., 2002), reaching an
isotropic resolution of 117 mm. Total brain volume (excluding olfactory bulb,
cerebellum, and brainstem) and, separately, the size of the lateral and third
ventricles, cerebellum, olfactory bulb, and brainstem were determined by
manually drawing respective regions of interest on up to 50 contiguous hori-
zontal MRI sections.
In Vivo 2P-LSM and In Vivo STED Nanoscopy
Two-photon microscopy (Agarwal et al., 2012) and STED imaging (Berning
et al., 2012) were performed as described. See the Supplemental Experimental
Procedures for details.
Behavioral Testing
For behavioral experiments, age-matched CK-Cre*Nrg1f/f, CK-Cre*Nrg1f/+,
Nrg1f/+, HA-Nrg1-tg, and WT mice at 12–15 weeks of age were used. Three
to fivemice per cage were housed in a roomwith a 12 hr light-dark cycle (lights
on at 9:00 a.m.) with ad libitum access to food andwater. Behavioral tests were
conducted in a blinded fashion during the light phase (10:00 a.m.–5:00 p.m.) as
described in Brzo´zka et al. (2010). Data are displayed as SEM, and statistical
significance was analyzed using a Mann-Whitney U test and a two-way
ANOVA with Bonferroni posttest (for multiple group comparisons). See the
Supplemental Experimental Procedures for details. All experiments were
performedwith permission from the local Animal Care andUseCommittee (Be-
zirksregierung Braunschweig) in accordance with the German Animal Protec-
tion Law.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.07.026.
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